260 related articles for article (PubMed ID: 7824502)
41. Antituberculosis drug resistance surveillance in Kenya, 1995.
Githui WA; Juma ES; van Gorkom J; Kibuga D; Odhiambo J; Drobniewski F
Int J Tuberc Lung Dis; 1998 Jun; 2(6):499-505. PubMed ID: 9626608
[TBL] [Abstract][Full Text] [Related]
42. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
[TBL] [Abstract][Full Text] [Related]
43. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
Al-Marri MR
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
[TBL] [Abstract][Full Text] [Related]
44. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
45. Multidrug-resistant tuberculosis in Denmark 1993-1995.
Viskum K; Kok-Jensen A
Int J Tuberc Lung Dis; 1997 Aug; 1(4):299-301. PubMed ID: 9432383
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003.
Anuradha B; Aparna S; Hari Sai Priya V; Vijaya Lakshmi V; Akbar Y; Suman Latha G; Murthy KJ
Int J Tuberc Lung Dis; 2006 Jan; 10(1):58-62. PubMed ID: 16466038
[TBL] [Abstract][Full Text] [Related]
47. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia.
Al-Rubaish AM; Madania AA; Al-Muhanna FA
Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451
[TBL] [Abstract][Full Text] [Related]
48. Drug resistance in Mycobacterium tuberculosis.
Cole ST; Telenti A
Eur Respir J Suppl; 1995 Sep; 20():701s-713s. PubMed ID: 8590570
[TBL] [Abstract][Full Text] [Related]
49. Drug-resistant tuberculosis in Korea, 1994.
Kim SJ; Bai GH; Hong YP
Int J Tuberc Lung Dis; 1997 Aug; 1(4):302-8. PubMed ID: 9432384
[TBL] [Abstract][Full Text] [Related]
50. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
51. Resistance to anti-tuberculosis drugs and practices in drug susceptibility testing in Moldova, 1995-1999.
Crudu V; Arnadottir T; Laticevschi D
Int J Tuberc Lung Dis; 2003 Apr; 7(4):336-42. PubMed ID: 12729338
[TBL] [Abstract][Full Text] [Related]
52. Drug-resistant tuberculosis in human immunodeficiency virus infected persons in Italy. The Italian Drug-Resistant Tuberculosis Study Group.
Angarano G; Carbonara S; Costa D; Gori A
Int J Tuberc Lung Dis; 1998 Apr; 2(4):303-11. PubMed ID: 9559401
[TBL] [Abstract][Full Text] [Related]
53. Human immunodeficiency virus-related tuberculosis and primary drug resistance in Bangkok, Thailand.
Punnotok J; Shaffer N; Naiwatanakul T; Pumprueg U; Subhannachart P; Ittiravivongs A; Chuchotthaworn C; Ponglertnapagorn P; Chantharojwong N; Young NL; Limpakarnjanarat K; Mastro TD
Int J Tuberc Lung Dis; 2000 Jun; 4(6):537-43. PubMed ID: 10864184
[TBL] [Abstract][Full Text] [Related]
54. Drug resistance among Mycobacterium tuberculosis isolates in Lebanon.
Hamze MM; Araj GF
Int J Tuberc Lung Dis; 1997 Aug; 1(4):314-8. PubMed ID: 9432386
[TBL] [Abstract][Full Text] [Related]
55. Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996-2005.
Mokaddas E; Ahmad S; Samir I
Int J Tuberc Lung Dis; 2008 Mar; 12(3):319-25. PubMed ID: 18284839
[TBL] [Abstract][Full Text] [Related]
56. The national tuberculosis drug resistance survey in Cambodia, 2000-2001.
Yamada N; Saorith K; Yamakami K; Onozaki I; Boran S; Fujiki A; Eang MT; Mori T
Int J Tuberc Lung Dis; 2007 Dec; 11(12):1321-7. PubMed ID: 18034953
[TBL] [Abstract][Full Text] [Related]
57. HIV infection and antituberculosis drug resistance among pulmonary tuberculosis patients in Harar Tuberculosis Centre, Ethiopia.
Mitike G; Kebede D; Yeneneh H
East Afr Med J; 1997 Mar; 74(3):154-7. PubMed ID: 9185411
[TBL] [Abstract][Full Text] [Related]
58. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
[TBL] [Abstract][Full Text] [Related]
59. Survey of primary drug resistance of Mycobacterium tuberculosis in Casablanca, Morocco.
el Baghdadi J; Lazraq R; Ibrahimy S; Bouayad Z; Guinet R; Benslimane A
Int J Tuberc Lung Dis; 1997 Aug; 1(4):309-13. PubMed ID: 9432385
[TBL] [Abstract][Full Text] [Related]
60. Association between HIV and tuberculosis: technical guide.
Bull Pan Am Health Organ; 1993; 27(3):297-310. PubMed ID: 8220525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
